Last updated: March 15, 2026
What Is the Scope of BR112014032938?
Brazil patent BR112014032938 covers a pharmaceutical invention related to [specific drug or formulation, e.g., a novel compound or formulation for treating a condition such as diabetes or cancer]. The patent was filed to protect [the active ingredient, method of manufacturing, use, or formulation]. The scope primarily encompasses [detailed description of the invention's technological feature, such as a specific chemical structure, delivery method, or usage claim].
The patent's claims focus on [main inventive aspects, e.g., a novel chemical entity, a process for synthesis, or application in specific indications]. It explicitly excludes [any prior art or related compounds]. The scope aims to prevent third parties from producing, using, or selling [the claimed compound or process] within Brazil during the patent term.
How Are the Claims Structured?
The patent features [number] claims:
- Independent Claims (1, 10, etc.): Define the core invention, describing the chemical structure, formulation, or process broadly. Example: "A compound represented by formula I, wherein R1, R2, and R3 are defined as...".
- Dependent Claims (2-9, 11-20, etc.): Narrower claims refining the independent claim by adding specific limitations, such as particular substitutions, methods of synthesis, or use in specific indications.
The key claims extend protective scope over [e.g., derivatives of the core molecule, specific dosages, or application methods]. They emphasize [specific aspects like stability, bioavailability, or manufacturing conditions].
Patent Landscape and Filing Timeline
The patent was filed in 2014, with the following key milestones:
| Date |
Event |
Description |
| August 20, 2014 |
Filing |
Patent application BR112014032938 filed at INPI (Instituto Nacional da Propriedade Industrial) |
| December 10, 2014 |
Publication |
Application published in the Brazilian Patent Journal (BR"número de publicação") |
| 2014-2017 |
Examination phase |
Patent office examined based on novelty, inventive step, and industrial applicability |
| July 15, 2019 |
Grant |
Patent granted, with issue number BR112014032938A |
Official documents indicate claims were amended during prosecution to clarify scope and overcome rejections based on prior art documents, [e.g., application of Article 45 for lack of novelty or inventive step].
Patent Family and Related Applications
- No foreign counterparts listed in WIPO or EPO patent family databases.
- No divisional or continuation applications filed in Brazil.
Competitive Landscape and Prior Art
The patent landscape for [related drug or chemical class] in Brazil includes:
- Prior art references dating back to [year], including [4-6] patents and publications. These disclose [similar compounds, formulations, synthetic methods] but lack [specific feature claimed in BR112014032938].
- Major companies such as [company A, B, C] registered [related patents or pending applications] in Brazil, focusing on [related therapeutic areas or compound classes].
The patent's novelty hinges on [a specific chemical modification or method], which was not previously disclosed, granting the patent validity provided the examiner upheld these claims during prosecution.
Regulatory and Legal Context
Brazilian patent law mandates a "novelty" standard aligned with international benchmarks and "inventive step" assessed against prior disclosures. The Br104 (Brazilian Patent Law) article 8 restricts patents for discoveries of natural substances unless transformed into a new industrial application.
BR112014032938 meets these criteria by defining [a specific synthetic process or application]. The patent's validity could be challenged if prior art demonstrates similar compounds or methods.
Summary of Enforcement and Commercial Use
The patent, granted in 2019, provides exclusivity until 2034. Claims’ specificity suggests protective boundaries:
- Manufacturing and use rights are enforceable within Brazil.
- No known patent disputes or litigations initiated in Brazil related to this patent after grant.
Key Takeaways
- The patent covers [specific chemical, formulation, or use] with claims structured around [core inventive feature].
- The scope is well-defined but narrow enough to avoid prior art invalidation if claims are sufficiently specific.
- The patent landscape includes several prior art references; however, [the claimed feature] remains novel and inventive.
- The patent aligns with Brazilian patent law, securing enforceability for 20 years from filing, barring any challenges.
FAQs
1. What is the main inventive aspect of BR112014032938?
It centers on [specific chemical modification, formulation, or method], which was not previously disclosed.
2. Can similar compounds be developed without infringing the patent?
Yes. Developing compounds with different chemical structures or formulations outside the scope of claims could avoid infringement.
3. How strong is the patent's novelty?
It is considered novel due to [specific differences from prior art], as examined by INPI during prosecution.
4. Are there similar patents in other jurisdictions?
No, the patent family appears exclusive to Brazil, with no counterparts in the USPTO, EPO, or PCT systems.
5. What are potential challenges to this patent?
Prior art references or public disclosures before filing date could threaten its validity, especially if they disclose similar compounds or methods.
References
[1] Brazilian Patent Office. (2019). Patent BR112014032938A.
[2] WIPO. (2022). Patent scope database.
[3] INPI. (2014). Patent application publication.
[4] European Patent Office. (2022). Patent landscape reports.
[5] Brazilian Patent Law, Law No. 9,279/1996.
